 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
IMMUCELL CP, (ICCC) Stock Rating Learn More
| Our Overall Rating on IMMUCELL CP, ICCC is Not Available | | ImmuCell Corporation, a biotechnology company, engages in the development, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industry. It sells its First Defense product, which is manufactured from cows' colostrums using the proprietary vaccine and milk protein purification technologies. First Defense is a U.S. Department of Agriculture-licensed, bivalent scours preventive product for calves on the market. ImmuCell is marketing and developing various products designed to aid in the management of mastitis, a disease in dairy cows. The companys Mast Out is a bovine mastitis treatment under development. The active ingredient in Mast Out is Nisin, a natural antibacterial peptide that can be found in dairy products. The product is being developed as an alternative to traditional antibiotics used in the treatment of mastitis in dairy cows. ImmuCells products primarily focus on the prevention, diagnosis, and treatment of bovine diseases. In addition, the companys Johne's Test is used to identify cattle with symptomatic Johne's disease, a chronic intestinal infection. ImmuCell was incorporated in 1982 and is headquartered in Portland, Maine. | | Our Not Available Rating on ICCC was issued on 12/02/2008 |
IMMUCELL CP Technical Rating
|
|
|
|
